Harbin Medisan is Pharmaceuticals in China that focus on Pharmaceutical Co Ltd business. Founded in 1996. They cover business area such as Harbin Medisan Pharmaceutical Co Ltd, development, manufacturing, sale, chemical preparation, oxiracetam injection, mirtazapine tablet, valsartan dispersible tablet, injection brain drug, protein hydrolysate, glucose injection, sodium chloride injection, research, production, medical device.
1996
( 28 years old in 2024 )
Pharmaceutical Co Ltd
-
Limin Development Zone in the middle of Beijing Road
Harbin, 150025
China
Private
Harbin Medisan Pharmaceutical Co Ltddevelopmentmanufacturingsalechemical preparationoxiracetam injectionmirtazapine tabletvalsartan dispersible tabletinjection brain drugprotein hydrolysateglucose injectionsodium chloride injectionresearchproductionmedical device
* We use standard office opening hours in near Harbin Medisan's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Harbin Medisan is Pharmaceuticals business from China that founded in 1996 (28 years old in 2024), Harbin Medisan business is focusing on Pharmaceutical Co Ltd.
Harbin Medisan headquarter office and corporate office address is located in Limin Development Zone in the middle of Beijing Road Harbin, 150025 China.
Harbin Medisan was founded in China.
In 2024, Harbin Medisan is currently focus on Pharmaceutical Co Ltd sector.
Above is snippet of Google Trends for "Pharmaceutical Co Ltd" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Harbin Medisan, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
